Healthcare >> CEO Interviews >> October 12, 2001
EDWARD O. LANPHIER II, the Founder of Sangamo BioSciences, Inc., has
served as President, Chief Executive Officer and a member of the Board
of Directors since the company's inception. Mr. Lanphier has
approximately 20 years of experience in the pharmaceutical and
biotechnology industry. From June 1992 to May 1997, he held various
positions at Somatix Therapy Corporation, a gene therapy company,
including Executive Vice President, Commercial Development, and Chief
Financial Officer. Prior to Somatix, Mr. Lanphier was President and
Chief Executive Officer of BioGrowth, Inc., a biotechnology company that
merged with Celtrix Laboratories to form Celtrix Pharmaceuticals, Inc.,
in 1991. From 1986 to 1987, Mr. Lanphier served as Vice President of
Corporate Development at Biotherapeutics, Inc. From 1984 to 1986 he
served as Vice President of Corporate Development at Synergen Inc. Prior
to Synergen, he was employed by Eli Lilly and Company, a pharmaceutical
company, in the strategic business planning-biotechnology group. Mr.
Lanphier is a member of the Biotechnology Industry Organization (BIO)
Emerging Companies Section and the BIO Board of Directors. Mr. Lanphier
has a BA in Biochemistry from Knox College. Profile
BioSciences?
Mr. Lanphier: Sangamo, which was founded in 1995, is focused on the
research and development of novel
